Baity Glenn
EVP AND GC at ACAD
- Sold, on record
- $14.3M
- Dollars the filings state
- Form 4 sales
- 20
- Latest Jan 29, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ACADACADIA PHARMACEUTICALS INCEVP AND GC
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale ACADUnusualFeb 14 2017
Sold 26,365 shares at $39.66 ($1M)
Baity Glenn, EVP AND GC
Sold 28.2% of holdings ($3.7M position)67,063 shares left2.6x usual sizeFiling
- 2 Form 4 sale ACADPlan not statedJun 22 +128 days
Sold 1,903 shares at $30.00 ($57k)
Baity Glenn, EVP AND GC
Sold 2.3% of holdings ($2.5M position)81,156 shares left0.2x usual sizeFiling
- 3 Form 4 sale ACADUnusualJul 20 +28 days
Sold 38,097 shares at $30.00 ($1.1M)
Baity Glenn, EVP AND GC
Sold 34.9% of holdings ($3.3M position)71,156 shares left3.8x usual sizeFiling
- 4 Form 4 sale ACADPlan not statedAug 9 +20 days
Sold 14,322 shares at $34.88 ($500k)
Baity Glenn, EVP AND GC
Sold 15.6% of holdings ($3.2M position)77,656 shares left1.4x usual sizeFiling
- 5 Form 4 sale ACADUnusualAug 30 +21 days
Sold 26,507 shares at $34.87 ($924k)
Baity Glenn, EVP AND GC
Sold 28.2% of holdings ($3.3M position)67,656 shares left2.2x usual sizeFiling
- 6 Form 4 sale ACADUnusualOct 5 +36 days
Sold 37,500 shares at $40.91 ($1.5M)
Baity Glenn, EVP AND GC
Sold 35% of holdings ($4.4M position)69,656 shares left2.6x usual sizeFiling
- 7 Form 4 sale ACADUnusualJan 2 +89 days
Sold 74,321 shares at $30.14 ($2.2M)
Baity Glenn, EVP AND GC
Sold 51.5% of holdings ($4.4M position)70,113 shares left4.9x usual sizeFiling
- 8 Form 4 sale ACADUnusualJan 29 +27 days
Sold 36,558 shares at $32.39 ($1.2M)
Baity Glenn, EVP AND GC
Sold 30.4% of holdings ($3.9M position)83,734 shares left2.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (20)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2018 | ACAD | EVP AND GC | Form 4 sale | 36,558 | $1.2M | 30.4% | Unusual | SEC |
| Jan 2, 2018 | ACAD | EVP AND GC | Form 4 sale | 74,321 | $2.2M | 51.5% | Unusual | SEC |
| Oct 5, 2017 | ACAD | EVP AND GC | Form 4 sale | 37,500 | $1.5M | 35.0% | Unusual | SEC |
| Aug 30, 2017 | ACAD | EVP AND GC | Form 4 sale | 26,507 | $924k | 28.2% | Unusual | SEC |
| Aug 9, 2017 | ACAD | EVP AND GC | Form 4 sale | 14,322 | $500k | 15.6% | Plan not stated | SEC |
| Jul 20, 2017 | ACAD | EVP AND GC | Form 4 sale | 38,097 | $1.1M | 34.9% | Unusual | SEC |
| Jun 22, 2017 | ACAD | EVP AND GC | Form 4 sale | 1,903 | $57k | 2.3% | Plan not stated | SEC |
| Feb 14, 2017 | ACAD | EVP AND GC | Form 4 sale | 26,365 | $1M | 28.2% | Unusual | SEC |
| Feb 1, 2017 | ACAD | EVP AND GC | Form 4 sale | 31,078 | $1.1M | 31.7% | Unusual | SEC |
| Dec 27, 2016 | ACAD | EVP AND GC | Form 4 sale | 9,800 | $299k | 12.0% | Plan not stated | SEC |
| Dec 20, 2016 | ACAD | EVP AND GC | Form 4 sale | 10,000 | $300k | 12.3% | Plan not stated | SEC |
| Nov 10, 2016 | ACAD | EVP AND GC | Form 4 sale | 10,200 | $307k | 13.9% | Plan not stated | SEC |
| Jul 12, 2016 | ACAD | EVP AND GC | Form 4 sale | 16,000 | $560k | 20.3% | Plan not stated | SEC |
| Mar 2, 2016 | ACAD | EVP AND GC | Form 4 sale | 7,000 | $146k | 10.0% | Plan not stated | SEC |
| Feb 26, 2014 | ACAD | VP AND GC | Form 4 sale | 42,000 | $1.3M | 46.8% | Unusual | SEC |
| Apr 22, 2013 | ACAD | VP AND GC | Form 4 sale | 10,000 | $132k | 20.0% | Plan not stated | SEC |
| Apr 17, 2013 | ACAD | VP AND GC | Form 4 sale | 50,000 | $619k | 55.6% | Unusual | SEC |
| Apr 12, 2013 | ACAD | VP AND GC | Form 4 sale | 60,000 | $745k | 60.0% | Unusual | SEC |
| Apr 2, 2013 | ACAD | VP AND GC | Form 4 sale | 13,163 | $105k | 24.8% | Plan not stated | SEC |
| Nov 28, 2012 | ACAD | VP AND GC | Form 4 sale | 20,602 | $125k | 32.3% | Unusual | SEC |